Bibliografias temáticas / Antibodies

Índice

  1. Artigos de revistas
  2. Teses / dissertações
  3. Livros
  4. Capítulos de livros
  5. Trabalhos de conferências
  6. Relatórios de organizações

Literatura científica selecionada sobre o tema "Antibodies"

Autor: Grafiati
Publicado: 4 de junho de 2021
Última modificação: 29 de julho de 2024

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Antibodies".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Artigos de revistas sobre o assunto "Antibodies"

1

Deora, Kanika, e Ruchee Khanna. "Clinical Profile of the Patients with Antiphospholipid Antibodies: Lupus Anticoagulant and Anticardiolipin Antibodies". Indian Journal of Forensic Medicine and Pathology 12, n.º 3 (2019): 195–99. http://dx.doi.org/10.21088/ijfmp.0974.3383.12319.6.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Chiswell, David J., e John McCaffery. "Phage antibodies: will new ‘coliclonal’ antibodies replace monoclonal antibodies?" Trends in Biotechnology 10 (1992): 80–84. http://dx.doi.org/10.1016/0167-7799(92)90178-x.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Linhardt, Robert J., C. W. Abell, R. M. Denney, B. W. Altrock, R. Auerbach, S. D. Bernal, R. E. Canfield et al. "Monoclonal antibodies and immobilized antibodies". Applied Biochemistry and Biotechnology 15, n.º 1 (junho de 1987): 53–80. http://dx.doi.org/10.1007/bf02798506.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Favoreel, Herman W., Geert Van Minnebruggen, Gerlinde R. Van de Walle, Jolanta Ficinska e Hans J. Nauwynck. "Herpesvirus interference with virus-specific antibodies: Bridging antibodies, internalizing antibodies, and hiding from antibodies". Veterinary Microbiology 113, n.º 3-4 (março de 2006): 257–63. http://dx.doi.org/10.1016/j.vetmic.2005.11.003.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Clark, A. "Antibodies". Journal of Clinical Pathology 42, n.º 5 (1 de maio de 1989): 559. http://dx.doi.org/10.1136/jcp.42.5.559-c.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Bradbury, Andrew, Nileena Velappan, Vittorio Verzillo, Milan Ovecka, Leslie Chasteen, Daniele Sblattero, Roberto Marzari, Jianlong Lou, Robert Siegel e Peter Pavlik. "Antibodies in proteomics I: generating antibodies". Trends in Biotechnology 21, n.º 6 (junho de 2003): 275–81. http://dx.doi.org/10.1016/s0167-7799(03)00112-4.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Kounis, Nicholas G., George D. Soufras e George N. Kounis. "Antibodies against antibodies inducing Kounis syndrome". International Journal of Cardiology 168, n.º 5 (outubro de 2013): 4804–5. http://dx.doi.org/10.1016/j.ijcard.2013.07.037.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Trier, Nicole, Paul Hansen e Gunnar Houen. "Peptides, Antibodies, Peptide Antibodies and More". International Journal of Molecular Sciences 20, n.º 24 (13 de dezembro de 2019): 6289. http://dx.doi.org/10.3390/ijms20246289.

Texto completo da fonte
Resumo:
The applications of peptides and antibodies to multiple targets have emerged as powerful tools in research, diagnostics, vaccine development, and therapeutics. Antibodies are unique since they, in theory, can be directed to any desired target, which illustrates their versatile nature and broad spectrum of use as illustrated by numerous applications of peptide antibodies. In recent years, due to the inherent limitations such as size and physical properties of antibodies, it has been attempted to generate new molecular compounds with equally high specificity and affinity, albeit with relatively low success. Based on this, peptides, antibodies, and peptide antibodies have established their importance and remain crucial reagents in molecular biology.
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Matraszek, Veronika Viktoria, Hynek Heřman e Ilona Hromadníková. "The relevance of antiphospholipid antibodies in obstetrics". Česká gynekologie 89, n.º 3 (22 de junho de 2024): 237–44. http://dx.doi.org/10.48095/cccg2024237.

Texto completo da fonte
Resumo:
Summary: Aim and methodology: To provide a comprehensive review on new findings and current recommendations regarding antiphospholipid antibodies with particular emphasis on clinical impact on gestation. Conclusion: Antiphospholipid antibodies are an important risk factor for the development of a series of pregnancy-related complications. Early diagnosis and appropriate therapy can reduce the incidence of pregnancy loss and pregnancy-related complications. Key words: antiphospholipid antibodies – antiphospholipid syndrome – lupus anticoagulant – anticardiolipin antibodies – anti-ß2-glycoprotein I antibodies
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Shoenfeld, Yehuda. "The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies". Nature Medicine 10, n.º 1 (janeiro de 2004): 17–18. http://dx.doi.org/10.1038/nm0104-17.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Teses / dissertações sobre o assunto "Antibodies"

1

Ng, King Man. "Anti-neurofascin antibodies". Diss., lmu, 2012. http://nbn-resolving.de/urn:nbn:de:bvb:19-150730.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Austin, Eric B. "Human monoclonal antibodies". Thesis, University of Nottingham, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.276187.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Evans, Rachael Yvonne. "The production of anti-idiotopic antibodies to monoclonal anti-RhD antibodies". Thesis, Lancaster University, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274194.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Kang, Sun-ah. "Apoptotic Cells, Anti-Phospholipid Antibodies, and Anti-Chromatin Antibodies in Autoimmunity". Diss., Temple University Libraries, 2008. http://cdm16002.contentdm.oclc.org/cdm/ref/collection/p245801coll10/id/15651.

Texto completo da fonte
Resumo:
Microbiology and Immunology
Ph.D.
Antiphospholipid antibodies (APAs) are detected in various autoimmune diseases, such as antiphospholipid syndrome (APS) and systemic lupus erythematosus. In addition to their binding to negatively charged phospholipids, APAs often cross-react with other molecules. Their potential biological effects are not fully understood. Apoptotic cells are a potential source of auto-antigens during systemic autoimmunity. Inefficient clearance of apoptotic cells results in the development of autoimmune manifestations and intracellular antigens such as nucleosomes become accessible during apoptosis. We examined a panel of monoclonal APAs generated from NZW/BXSB F1, a strain which spontaneously develops autoimmune symptoms reminiscent of APS. These APAs did not bind to live cells, but reacted strongly with different structures within apoptotic cells. Further analysis with various inhibitors indicated that the binding of APAs to apoptotic cells depends on specific caspase activities and on the modification of auto-antigens by reactive oxygen species (ROS). Therefore, apoptotic cells provide a potential source of APA antigens that may not be limited to phospholipids. Our data also indicate that physical accessibility and apoptosis-specific modification of auto-antigens by caspases or ROS are crucial factors for APA-antigen interactions. Various auto-antibodies such as APAs and anti-chromatin antibodies are pathogenic outcome of chronic autoimmune diseases. Their binding to auto-antigens, presumably exposed on apoptotic cells, elicits subsequent amplification of inflammatory responses, thus worsening disease progression. However, the precise immunological functions of auto-antibodies and the mechanism behind are not fully comprehended yet. We investigated immune responses generated by four different auto-immune complexes (auto-ICs) composed of auto-antibodies and apoptotic cells. In the presence of TLR ligation, the presence of auto-antibodies in auto-ICs amplified immune responses generated by apoptotic cells. In most cases, almost all the auto-ICs tested suppressed IL12, TNFa, while increasing IL10 production from macrophages. Further studies with various anti-Fc?R antibodies implied the essential role of various Fc?Rs in elevation of IL10 by auto-ICs. Studies with Mer-/- macrophages indicated that Mer is also crucial in auto-IC mediated augmentation of IL10 production. However, Mer was dispensable for the suppression of IL12. Taken together, auto-antibodies, by forming immune complexes with apoptotic cells, perform strong immunomodulatory functions. Particular importance is in the role of Fc?Rs and Mer in anti-inflammatory responses generated by auto-ICs. Paradoxical, but indispensible contribution of TLR ligation, especially TLR4, in anti-inflammatory responses generated by auto-ICs suggests that auto-antibodies may work as another layer of defense against endogenous danger signals.
Temple University--Theses
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Chmura, A. J. "Rational engineering of antibodies with irreversible binding : antibodies with infinite affinity /". Connect to Digital dissertations. Restricted to UC campuses. Access is free to UC campus dissertations, 2001. http://uclibs.org/PID/11984.

Texto completo da fonte
Resumo:
Thesis (Ph. D.)--University of California, Davis, 2002.
Degree granted in Chemistry. Dissertation completed in 2001; degree granted in 2002. Also available via the World Wide Web. (Restricted to UC campuses).
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Rada-Briega, Cristina. "Somatic hypermutation of antibodies". Thesis, University of Cambridge, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.318450.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Plumpton, Christopher. "Monoclonal antibodies against phytochrome". Thesis, University of Cambridge, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.358677.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Bentall, Andrew John. "Antibodies in kidney transplantation". Thesis, University of Birmingham, 2015. http://etheses.bham.ac.uk//id/eprint/5817/.

Texto completo da fonte
Resumo:
The aim of this thesis is to examine the effect of anti-donor antibodies in the clinical management and outcomes of antibody incompatible kidney transplantation. Initial studies were conducted to improve measurement of anti-ABO specific blood group antibodies. The specificity of antibody binding to blood group antigens (BGA) depended upon the assay platform and the nature of the core structure to which the BGA was bound. A standardised haemagglutination assay had excellent reproducibility, which was then applied to the analysis of samples derived from a study of 100 ABO incompatible kidney transplantation (ABOiKTx) in the UK where good clinical outcomes were achieved but there was wide variation reported in local assays quantifying BGA specific antibodies, without survival differences. In a highly sensitised HLA incompatible kidney transplant recipients (HLAiKTx), I demonstrated long term outcomes were poor compared to a compatible cohort, in particular with pre-formed donor specific anti-HLA Class II antibodies, in which histological injury of antibody damage occurred significantly earlier than with Class I antibodies. Further studies demonstrated that anti-HLA antibodies were associated with an inflammatory phenotype, but anti-donor ABO specific antibodies did not despite the activation of complement. Thus, inhibiting terminal complement activation, whilst reducing early antibody-mediated rejection did not abrogate all inflammation which was associated with the presence of IgM DSA. Reproducible and standardised assays are needed for antibody assessment in order to make good clinical decisions to improve patient outcomes. Further studies are needed to stop production or block mechanisms of ongoing cellular infiltrate to improve patient outcomes.
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Alcocer, Marcos J. C. "Wheat peptides and antibodies". Thesis, University of East Anglia, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.306066.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Farzad, Zohreh (Emami Aleagha). "Studies on anti-tetanus antibodies". Thesis, University of Edinburgh, 1985. http://hdl.handle.net/1842/23886.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Livros sobre o assunto "Antibodies"

1

Szentivanyi, Andor, Paul H. Maurer e Bernard W. Janicki, eds. Antibodies. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Subramanian, G., ed. Antibodies. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8875-1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Subramanian, G., ed. Antibodies. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4419-8877-5.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Anderson, Kevin J. Antibodies. New York: HarperPrism, 1998.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Anderson, Kevin J. Antibodies. New York, N.Y: HarperPrism, 1997.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Anderson, Kevin J. Antibodies. New York: HarperCollins, 2008.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Anderson, Kevin J. Antibodies. London: HarperCollins, 1997.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

1935-, Subramanian G., ed. Antibodies. New York: Kluwer Academic/Plenum Publishers, 2004.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

1935-, Subramanian G., ed. Antibodies. New York: Kluwer Academic/Plenum Publishers, 2004.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Skal, David J. Antibodies. New York: Congdon & Weed, 1988.

Encontre o texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Mais fontes

Capítulos de livros sobre o assunto "Antibodies"

1

Dorrington, Keith J., e Michel H. Klein. "The Three-Dimensional Structure of Immunoglobulin G and its Relationship to the Expression of Biological Functions". In Antibodies, 3–10. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_1.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Siskind, Gregory W., Edmond A. Goidl, Young Tai Kim, Marc E. Weksler e G. Jeanette Thorbecke. "Anti-Hapten Idiotype Models in Studies of Aging and Idiotype Networks". In Antibodies, 107–15. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_10.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Erlanger, B. F., W. L. Cleveland, N. H. Wasserman, H. H. Ku, B. L. Hill, R. Sarangarajan, R. Rajagopalan et al. "Antibodies to Acetylcholine, Adenosine and Glucocorticoid Receptors by an Auto-Anti-Idiotypic Route". In Antibodies, 119–34. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_11.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Geha, Raif S. "Idiotypic Interactions in the Treatment of Human Diseases". In Antibodies, 135–53. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_12.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Talal, Norman. "Regulation of Autoimmune Diseases". In Antibodies, 155–63. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_13.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Morrison, Sherie L., Letitia A. Wims, Polly D. Gregor, Barry J. Kobrin e Vernon T. Oi. "Transfectomas Provide Antibodies with Novel Structures and Functions". In Antibodies, 167–78. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_14.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Uhr, Jonathan W., R. Jerrold Fulton e Ellen S. Vitetta. "The Use of Ricin a Chain-Containing Immunotoxins to Kill Neoplastic B Cells". In Antibodies, 179–87. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_15.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Oldham, Robert K. "Monoclonal Antibodies and Immunoconjugates as Anti-Cancer Agents". In Antibodies, 189–200. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_16.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Siskind, Gregory W. "Overview and Comments". In Antibodies, 203–6. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_17.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Kohler, Heinz, e Thomas Kieber-Emmons. "New Concepts in Antibody Structure". In Antibodies, 11–17. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1873-6_2.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Trabalhos de conferências sobre o assunto "Antibodies"

1

NERI, DARIO. "FROM INTACT ANTIBODIES TO ARMED ANTIBODIES". In 23rd International Solvay Conference on Chemistry. WORLD SCIENTIFIC, 2014. http://dx.doi.org/10.1142/9789814603836_0036.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Kiefel, V., S. Santoso e C. Mueller-Eckhardt. "ANALYSIS OF PLATELET REACTIVE ANTIBODIES USING MONOCLONAL ANTIBODIES". In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643929.

Texto completo da fonte
Resumo:
The characterization of platelet reactive alloantibodies and autoantibodies is mandatory for the diagnosis of posttransfusion purpura, neonatal alloimmune thrombocytopenia, autoimmune thrombocytopenia and for the selection of platelet donors prior to platelet transfusions in immunized polytransfused patients. The platelet immunofluorescence test is suitable for the detection of platelet reactive antibodies. In many cases, however, mixtures containing different platelet reactive antibodies have to be dissected.In order to analyze these sera, we have developed a novel enzyme immunoassay based upon monoclonal antibody specific immobilization of platelet antigens (MAIPA). In brief, platelets are incubated simultaneously with the (human) serum to be investigated and a monoclonal (mouse) antibody directed against an epitope on the same platelet membrane glycoprotein (GP). Platelets are then washed and solubilized in TRIS buffered saline containing NP40. The lysed platelets are then pipetted into the wells of microtiter plates, coated with goat anti mouse IgG where mouse anti GP-complexes are immobilized. Human platelet reactive antibodies on the same GP are detected using enzyme labelled goat anti human IgG, IgM, or IgA, respectively. Using mab Gi5, mab FMC25, mab w6.32 directed against epitopes on the glycoprotein complex IIb/IIIa, glycoprotein Ib and HLA class I molecule, respectively, and a panel of typed platelet donors, even sera containing different platelet reactive antibodies are readily analyzed. Results of experiments with platelet specific alloantibodies (anti P1A1, anti P1A2 and anti Bak(a)), autoantibodies (against the GP Ilb/IIIa complex and GP Ib) and a drug dependent antibody show that this assay allows to discriminate all these different platelet reactive antibodies.
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Bundell, C., e P. Hollingsworth. "359 Antinuclear antibodies in iu/ml predicts dsdna and ena antibodies". In LUPUS 2017 & ACA 2017, (12th International Congress on SLE &, 7th Asian Congress on Autoimmunity). Lupus Foundation of America, 2017. http://dx.doi.org/10.1136/lupus-2017-000215.359.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Zanlorenzi, Laís, Nelzi Ferreira de Queiroz Junior, Carlos Gomes Bezerra Sobrinh, Laura Vilas Boas, Renato Nishiara e Thelma Skare. "ANTINUCLEAR ANTIBODIES IN ENDOMETRIOSIS". In SBR 2021 Congresso Brasileiro de Reumatologia. Sociedade Brasileira de Reumatologia, 2021. http://dx.doi.org/10.47660/cbr.2021.2009.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

ESHHAR, ZELIG. "GENETICALLY ENGINEERED THERAPEUTIC ANTIBODIES". In International Seminar on Nuclear War and Planetary Emergencies 25th Session. Singapore: World Scientific Publishing Co. Pte. Ltd., 2001. http://dx.doi.org/10.1142/9789812797001_0062.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

SIROTA, PINKHAS, KLARA SCHILD, MICHAEL FIRER, NEOMI ZURGIL, YORAM BARAK, AVNER ELIZUR e HANOCH SLOR. "ANTI Sm ANTIBODIES IN SCHIZOPHRENIA". In IX World Congress of Psychiatry. WORLD SCIENTIFIC, 1994. http://dx.doi.org/10.1142/9789814440912_0014.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Ivanova, SM, GG Karpova, NV Bogachiova, TA Riazantctva e AI Speranskey. "THU0061 Ribosomal p protein antibodies". In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.905.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Sun, Yanjie, Zhuoyun Wan e Zixiao Zhang. "Therapeutic Monoclonal Antibodies: Clinical Applications". In International Conference on Biotechnology and Biomedicine. SCITEPRESS - Science and Technology Publications, 2022. http://dx.doi.org/10.5220/0012020800003633.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Cucnik, Sasa. "SP0176 PATHOGENIC ANTIBODIES IN PHOSPHOLIPID SYNDROM". In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.8453.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

SIDHU, SACHDEV S. "FROM NATURAL ANTIBODIES TO SYNTHETIC PROTEINS". In 23rd International Solvay Conference on Chemistry. WORLD SCIENTIFIC, 2014. http://dx.doi.org/10.1142/9789814603836_0035.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.

Relatórios de organizações sobre o assunto "Antibodies"

1

Benkovic, Stephen J. Catalytic Antibodies. Fort Belvoir, VA: Defense Technical Information Center, março de 1992. http://dx.doi.org/10.21236/ada252019.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
2

Ivy, John M. Production of Anti-Ferret IgA Antibodies; and production of monoclonal antibodies. Fort Belvoir, VA: Defense Technical Information Center, abril de 1994. http://dx.doi.org/10.21236/ada279534.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
3

Bradley, David Sherman. Avian Diagnostic and Therapeutic Antibodies. Office of Scientific and Technical Information (OSTI), dezembro de 2012. http://dx.doi.org/10.2172/1114116.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
4

Snyder, Christopher M., e Lawrence J. Wysocki. Dissecting Immunogenicity of Monoclonal Antibodies. Fort Belvoir, VA: Defense Technical Information Center, junho de 2002. http://dx.doi.org/10.21236/ada407659.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
5

Snyder, Christopher M., e Lawrence J. Wysocki. Dissecting Immunogenicity of Monoclonal Antibodies. Fort Belvoir, VA: Defense Technical Information Center, junho de 2003. http://dx.doi.org/10.21236/ada417364.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
6

Jaszczak, R. J. SPECT assay of radiolabeled monoclonal antibodies. Office of Scientific and Technical Information (OSTI), fevereiro de 1992. http://dx.doi.org/10.2172/7197646.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
7

Jaszczak, R. J. SPECT assay of radiolabeled monoclonal antibodies. Office of Scientific and Technical Information (OSTI), fevereiro de 1992. http://dx.doi.org/10.2172/7288347.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
8

Borgford, Thor. Human-based Polyclonal Antibodies to Ricin. Fort Belvoir, VA: Defense Technical Information Center, maio de 2010. http://dx.doi.org/10.21236/ada533217.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
9

Clynes, Raphael. Cytotoxic Mechanisms of Tumor Specific Antibodies. Fort Belvoir, VA: Defense Technical Information Center, outubro de 2002. http://dx.doi.org/10.21236/ada411736.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
10

Clynes, Raphael. Cytotoxic Mechanisms of Tumor Specific Antibodies. Fort Belvoir, VA: Defense Technical Information Center, outubro de 2000. http://dx.doi.org/10.21236/ada392896.

Texto completo da fonte
Estilos ABNT, Harvard, Vancouver, APA, etc.
Você também pode estar interessado nas extensas listas de trabalhos sobre o assunto "Antibodies":
Artigos de revistas Teses / dissertações Livros
Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!

Vá para a bibliografia